Skip to main content
Top
Published in: Annals of Hematology 12/2003

01-12-2003 | Case Report

Hereditary spherocytosis associated with mutations in HFE gene

Authors: M. A. Montes-Cano, F. Rodríguez-Muñoz, R. Franco-Osorio, A. Núñez-Roldán, M. F. González-Escribano

Published in: Annals of Hematology | Issue 12/2003

Login to get access

Abstract

We report on a Spanish family in which three members of different generations were diagnosed with hereditary spherocytosis (HS). Additionally, one of them II-I (44-years-old), presented iron overload with hepatic deposit and needed treatment with periodic phlebotomies. The rest of the family members presented normal analytical values in iron metabolism. To investigate the presence of H63D and C282Y mutations in the HFE gene, patient II-I was found to be compound heterozygous and was the only family member presenting HS and this genetic condition in HFE. We propose a synergistic effect of HS and mutations in HFE as the cause of the iron deposits.
Literature
1.
go back to reference Dacie J (1985) Hereditary spherocytosis (HS). In: The Haemolytic Anaemias, 3rd edn. Churchill Livingstone, Edinburg, pp 134–215 Dacie J (1985) Hereditary spherocytosis (HS). In: The Haemolytic Anaemias, 3rd edn. Churchill Livingstone, Edinburg, pp 134–215
2.
go back to reference Ayala S, Besson I, Aymerich M, Berga L, Vives Corrons JL (1995) Abnormalities of red blood cells membrane proteins in hereditary spherocytosis and their relationship with clinical and biological aspects of the disease. Med Clin (Barc) 105:45–49 Ayala S, Besson I, Aymerich M, Berga L, Vives Corrons JL (1995) Abnormalities of red blood cells membrane proteins in hereditary spherocytosis and their relationship with clinical and biological aspects of the disease. Med Clin (Barc) 105:45–49
3.
go back to reference Palek J, Jarolim P (1995) Hereditary spherocytosis, elliptocytosis, and related disorders. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds) Hematology, 5th edn. McGraw-Hill, New York, pp 536–557 Palek J, Jarolim P (1995) Hereditary spherocytosis, elliptocytosis, and related disorders. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds) Hematology, 5th edn. McGraw-Hill, New York, pp 536–557
4.
go back to reference Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK, et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408PubMed Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK, et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408PubMed
5.
go back to reference Hasson EH, Imperatore G, Burke W (2001) HFE gene and hereditary hemochromatosis: a HuGE review. Human genome epidemiology. Am J Epidemiol 154:193–206CrossRefPubMed Hasson EH, Imperatore G, Burke W (2001) HFE gene and hereditary hemochromatosis: a HuGE review. Human genome epidemiology. Am J Epidemiol 154:193–206CrossRefPubMed
6.
go back to reference Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux G-P, Blanc F, Blanc P, Schved JF, Larrey D (2001) Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 48:836–842CrossRefPubMed Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux G-P, Blanc F, Blanc P, Schved JF, Larrey D (2001) Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 48:836–842CrossRefPubMed
7.
go back to reference Beutler E (1997) The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 61:762–764PubMed Beutler E (1997) The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 61:762–764PubMed
8.
go back to reference Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, Girelli D, Roetto A, Franco B, Gasparini P, Camaschella C (1997) Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 60:828–832PubMed Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, Girelli D, Roetto A, Franco B, Gasparini P, Camaschella C (1997) Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 60:828–832PubMed
9.
go back to reference Holmstrom P, Marmur J, Eggertsen G, Gafvels M, Stal P (2002) Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51:723–730CrossRefPubMed Holmstrom P, Marmur J, Eggertsen G, Gafvels M, Stal P (2002) Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51:723–730CrossRefPubMed
10.
go back to reference Edwards CQ, Griffen LM, Goldgar D, Drummod C, Skolnick MH, Kushner JP (1988) Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 318:1355–1362PubMed Edwards CQ, Griffen LM, Goldgar D, Drummod C, Skolnick MH, Kushner JP (1988) Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 318:1355–1362PubMed
11.
go back to reference Kawasaki E (1990) Sample preparation from blood, cells and other fluids. In: Innis M, Gelfand D, Snisky J, White T (eds) PCR protocols. A guide to methods and applications. Academic Press, San Diego, pp 146–152 Kawasaki E (1990) Sample preparation from blood, cells and other fluids. In: Innis M, Gelfand D, Snisky J, White T (eds) PCR protocols. A guide to methods and applications. Academic Press, San Diego, pp 146–152
12.
go back to reference Montes-Cano M, González-Escribano MF, Aguilar J, Núñez-Roldán A (2002) Juvenile hemochromatosis in a Spanish family. Blood Cells Mol Dis 28:297–300CrossRefPubMed Montes-Cano M, González-Escribano MF, Aguilar J, Núñez-Roldán A (2002) Juvenile hemochromatosis in a Spanish family. Blood Cells Mol Dis 28:297–300CrossRefPubMed
13.
go back to reference Brandenberg JB, Demarmels Biasiutti F, Lutz HU, Wuillemin WA (2002) Hereditary spherocytosis and hemochromatosis. Ann Hematol 81:202–209CrossRef Brandenberg JB, Demarmels Biasiutti F, Lutz HU, Wuillemin WA (2002) Hereditary spherocytosis and hemochromatosis. Ann Hematol 81:202–209CrossRef
14.
go back to reference Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Sánchez-Ansaldo J, Ruiz-Delgado GJ, Jiménez-González C, Carrera B (2001) Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in β-thalassemia minor: observation in a thalassemic kindred. Rev Invest Clin 53:117–120PubMed Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Sánchez-Ansaldo J, Ruiz-Delgado GJ, Jiménez-González C, Carrera B (2001) Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in β-thalassemia minor: observation in a thalassemic kindred. Rev Invest Clin 53:117–120PubMed
15.
go back to reference Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799–1805PubMed Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799–1805PubMed
Metadata
Title
Hereditary spherocytosis associated with mutations in HFE gene
Authors
M. A. Montes-Cano
F. Rodríguez-Muñoz
R. Franco-Osorio
A. Núñez-Roldán
M. F. González-Escribano
Publication date
01-12-2003
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 12/2003
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0733-y

Other articles of this Issue 12/2003

Annals of Hematology 12/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.